Evaluation of a single dose versus a divided dose regimen of danofloxacin in treatment of Actinobacillus pleuropneumoniae infection in pigs

Research in Veterinary Science

Volumn 74, Issue 3, 2003, Pages 271-277

  Lauritzen, Brian ^a   Lykkesfeldt, Jens ^a   Friis, Christian ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Actinobacillus pleuropneumoniae; Ascorbic acid; C reactive protein; Danofloxacin; Pigs; Zinc

Indexed keywords

ANTIINFECTIVE AGENT; ASCORBIC ACID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DANOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ZINC;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL OBSERVATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG SCREENING; EXPERIMENTAL INFECTION; GRAM NEGATIVE INFECTION; HEMATOLOGICAL PARAMETERS; LOW DRUG DOSE; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RELAPSE; SINGLE DRUG DOSE; SWINE DISEASE; TEMPERATURE; TIME;

ACTINOBACILLUS; ACTINOBACILLUS PLEUROPNEUMONIAE; SUIDAE;

EID: 0037763948     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-5288(03)00029-8     Document Type: Article

References (21)

1. Blaser, J., Stone, B.B., Groner, M.C., Zinner, S.H., 1987. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrobial Agents and Chemotherapy 31, 1054-1060.
2. Brown, S.A., 1996. Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics 19, 1- 14.
3. Craig, W.A., 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 26, 1-12.
4. Cruijsen, T.L.M., Van Leengoed, L.A.M.G., Dekker-Nooren, T.C.E.M., Schoevers, E.J., Verheijden, J.H.M., 1992. Phagocytosis and killing of Actinobacillus pleuropneumoniae by alveolar macrophages and polymorphonuclear leukocytes isolated from pigs. Infection and Immunity 60, 4867-4871.
5. Dom, P., Haesebrouck, F., Ducatelle, R., Charlier, G., 1994. In vivo association of Actinobacillus pleuropneumoniae serotype 2 with the respiratory epithelium of pigs. Infection and Immunity 64, 1262-1267.
6. Drusano, G.L., Johnson, D.E., Rosen, M., Standiford, H.C., 1993. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy 37, 483-490.
7. Forrest, A., Nix, D.E., Ballow, C.H., Goss, T.F., Birmingham, M.C., Schentag, J.J., 1993. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy 37, 1073-1081.
8. Friis, C., 1993. Penetration of danofloxacin into the respiratory tract tissue and secretions in calves. American Journal of Veterinary Research 54, 1122- 1127.
9. Friis, C., Nielsen, J.P., 1997. Penetration of danofloxacin into the respiratory tract tissues and secretions in healthy and Actinobacillus pleuropneumoniae infected pigs. Journal of Veterinary Pharmacology and Therapeutics 20 (Suppl. 1), 108-109.
10. Kiorpes, A.L., Macwilliams, P.S., Schenkman, D.I., Bäckström, L.R., 1990. Blood gas and hematological changes in experimental peracute porcine pleuropneumonia. Canadian Journal of Veterinary Research 54, 164-169.
11. Lauritzen, B., Lykkesfeldt, J., Skaanild, M.T., Angen, Ø, Nielsen, J.P., Friis, C., 2003. Putative biomarkers for evaluating antibiotic treatment: An experimental model of porcine Actinobacillus pleuropneumoniae infection. Research in Veterinary Science 74, 261-270.
12. Leggett, J.E., Ebert, S., Fantin, B., Craig, W.A., 1991. Comparative dose-effect relations at several dosing intervals for β-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models. Scandinavian Journal of Infectious Diseases (Suppl. 74), 179-184.
13. Lindecrona, R.H., Friis, C., Jensen, N.E., 1999. The pharmacodynamic effect of amoxycillin and danofloxacin against Actinobacillus pleuropneumoniae in an in vitro pharmacodynamic model. Research in Veterinary Science 67, 93-97.
14. Lykkesfeldt, J., 2000. Determination of ascorbic acid and dehydroascorbic acid in biological samples by high-performance liquid chromatography using subtraction methods: reliable reduction with tris[2-carboxyethyl]phosphine hydrochloride. Analytical Biochemistry 282, 89-93.
15. Mann, D.D., Frame, G.M., 1991. Pharmacokinetic study of danofloxacin in cattle and swine. American Journal of Veterinary Research 53, 1022-1026.
16. McKellar, Q.A., Aliabadi, F.S., Donchie, W., Marr, K.A., Rowan, T.G., Sarasola, P., Lees, P., 2000. Concentration-dependent pharmacodynamics of danofloxacin in cattle. Abstracts of the 8th Congress of the European Association of Veterinary Pharmacology and Toxicology, Jerusalem, Israel, 2000. Journal of Veterinary Pharmacology and Toxicology 23 (Suppl. 1).
17. McKellar, Q.A., Gibson, I.F., Mccormack, R.Z., 1998. Pharmacokinetics and tissue disposition of danofloxacin in sheep. Biopharmaceutics and Drug Disposition 19, 123-129.
18. Richez, P., Pedersen Mörner, A., De Jong, A., Monlouis, J.D., 1997. Plasma pharmacokinetics of parenterally administered danofloxacin and enrofloxacin in pigs. Journal of Veterinary Pharmacology and Therapeutics 20 (Suppl. 1), 108-109.
19. Shem-Tov, M., Rav-Hon, O., Ziv, G., Lavi, E., Glickman, A., Saran, A., 1998. Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows. Journal of Veterinary Pharmacology and Therapeutics 21, 209-213.
20. Shojaee AliAbadi, F., Lees, P., 2000. Antibiotic treatment for animals: affect on bacterial population and dosage regimen optimisation. International Journal of Antimicrobial Agents 14, 307-313.
21. Taylor, D.J., 1999. Actinobacillus pleuropneumoniae. In: Straw, B.E., D'Allaire, S., Mengeling, W.L., Taylor, D.J. (Eds.), Diseases of Swine, eighth ed.. Iowa State University Press, Ames, Iowa, USA, pp. 343-354.